Efficacy and Safety of Apremilast in Oncological Patients with Moderate-to-Severe Plaque Psoriasis: A 5 years Retrospective Observational Study
Caterina Lanna,1 Antonia Rivieccio,1 Martina Vultaggio,1 Ruslana Gaeta Shumak,1 Francesco Maria Bonacci,1 Fabio Artosi,1 Cristiana Borselli,1 Gaetana Costanza,2 Luca Bianchi,1 Elena Campione1 1Dermatology Unit, Department of Systems Medicine, Università di Roma Tor Vergata, Roma, Italia; 2Virology U...
Saved in:
Main Authors: | Lanna C, Rivieccio A, Vultaggio M, Gaeta Shumak R, Bonacci FM, Artosi F, Borselli C, Costanza G, Bianchi L, Campione E |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-05-01
|
Series: | Clinical, Cosmetic and Investigational Dermatology |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-safety-of-apremilast-in-oncological-patients-with-moderat-peer-reviewed-fulltext-article-CCID |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical experience with apremilast for psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2018-09-01) -
Initiation of apremilast treatment decreases prescribed topical therapy amount in patients with psoriasis: a health insurance claims study in Japan
by: Siddharth Chaudhari, et al.
Published: (2025-12-01) -
APREMILAST: AN UPDATE ON ITS EFFICACY AND SAFETY DURING LONG-TERM TREATMENT OF PATIENTS WITH PSORIATIC ARTHRITIS
by: Yu. L. Korsakova, et al.
Published: (2018-11-01) -
New opportunities in the treatment of psoriasis and psoriatic arthritis
by: A. A. Kubanov, et al.
Published: (2019-01-01) -
The place of a phosphodiesterase 4 inhibitor in the treatment strategy for psoriatic arthritis
by: V. I. Mazurov, et al.
Published: (2018-04-01)